Alternatively, the Acessa procedure is performed on an outpatient basis and has demonstrated that patients typically go home the same day, resume normal activities within three to four days, and experience rapid and significant reduction in fibroid symptoms. "I believe that the Accessa procedure is on track to become the premier procedure for women who want to treat their fibroids with minimal damage to the uterus." Dr. Williams says.
The Accessa procedure consists of an outpatient, minimally invasive procedure which utilizes ultrasound, laparoscopic visualization, and radiofrequency ablation to target the fibroids specifically while leaving normal uterine tissue intact. By treating all of the fibroids, studies have shown that the risk of recurrence is low and symptom reduction is high.
Interest in this outpatient fibroid treatment is growing rapidly because it’s highly effective, it’s less invasive than most other surgical alternatives, and recovery and symptom relief are fast. Also, the need for further fibroid treatment is low, as demonstrated by clinical studies in which 90 percent of patients three years after the procedure did not require further medical or surgical treatment.
“Acessa represents a breakthrough solution for women that relieves the pain, pressure and other symptoms of fibroids without a hysterectomy and using an outpatient procedure that's likely to be the last fibroid treatment they'll need,” said Jeffrey M. Cohen, CEO of Halt Medical.
For information about the Acessa System, please visit www.haltmedical.com. To connect with Halt Medical on Facebook visit www.facebook.com/
For information about the Gynecology Institute of Chicago and Dr. Nicole E. Williams, MD, FACOG, visit www.gynecologyinstitute.com.